<DOC>
	<DOCNO>NCT00340704</DOCNO>
	<brief_summary>Aims study characterize pharmacokinetic/pharmacodynamic profile evaluate safety , efficacy tolerability , tamsulosin hydrochloride treatment child neuropathic bladder , course 12 month active treatment .</brief_summary>
	<brief_title>PK/PD , Long-term Safety Efficacy Tamsulosin Treatment Children With Neurogenic Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Neuropathic bladder secondary know neurological disorder Elevated detrusor leak point pressure ( LPP ) â‰¥40 cm H2O confirm two measurement baseline Clinically significant abnormality determine investigator A history relevant orthostatic hypotension , faint spell blackout</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>tamsulosin</keyword>
	<keyword>pediatric</keyword>
	<keyword>neurogenic bladder</keyword>
</DOC>